ICN Test to Detect Hereditary Disorders in Newborns
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




ICN Test to Detect Hereditary Disorders in Newborns

COSTA MESA, Calif., Jan. 23, 1996 - ICN Pharmaceuticals, Inc. (NYSE: ICN) announced that it has received authorization from the Food and Drug Administration (FDA) to market an important new test for Galactosemia in newborn infants.

Galactosemia is a hereditary metabolic disorder found in infants, which may affect one in 30,000 newborns. The ICN test is a quantitative enzyme assay in a microplate format.

ICN's test provides a convenient alternative to the earlier screening tests utilizing bacteria, particularly in offering enhanced assay performance, automation and same-day results. Early diagnosis allows doctors to quickly prescribe galactose-free diets in order to reduce the levels of the sugar circulating in the infant's blood. Classical galactosemia in infants, left untreated, is characterized by enlargement and subsequent damage to the liver and brain, cataract formation, and failure to thrive. Testing for galactosemia is becoming increasingly mandatory throughout the United States. ICN will begin marketing the test immediately.

ICN Pharmaceuticals, Inc. is a worldwide healthcare company that manufactures, markets and distributes a range of prescription and non-prescription pharmaceuticals, biotechnology research products and medical diagnostics.

CONTACT: Jennifer Openshaw of ICN, 714-545-0100, ext. 2202 (ICN)

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities